Nov 10, 2020
This week, we are joined by Pierre Bourdage, Global Head
Biopharmaceuticals, Sandoz, who provides insight into the state and
future of the biosimilars market, discusses how to adapt to 'the
new normal', and shares the lessons he learnt as a member of the
Canadian Grenadier Guards.